Side-by-side comparison of AI visibility scores, market position, and capabilities
Beiersdorf's flagship skincare brand generating €5.7B revenue with iconic blue tin NIVEA Cream; sold in 200+ countries competing with Dove and Olay for global mass-market body and face care.
NIVEA is one of the world's most recognized skincare brands — offering body care (classic NIVEA Cream in the iconic blue tin, body lotions, body wash), face care (moisturizers, cleansers, serums), sun protection (SPF body and face products), and lip care (NIVEA Lip Balm) formulated for everyday use at mass-market price points. Owned by Beiersdorf AG (ETR: BEI), a Hamburg-based consumer goods company, NIVEA is Beiersdorf's flagship brand generating €5.7 billion of Beiersdorf's €10.7 billion total annual revenue, sold in 200+ countries.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.